AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 17569256 — intervention group
Group type: EXPERIMENTAL
Intervention: HER-2/neu over-expression in androgen independent prostate cancer (33%)
Number of subjects: 54
Study 17569256 — intervention group
Group type: COMPARATOR
Intervention: HER-2/neu over-expression in Gleason score >7 group (14.29%)
Number of subjects: 54
Study 17569256 — intervention group
Group type: COMPARATOR
Intervention: HER-2/neu over-expression in clinical stage > T2 group (34.62%)
Number of subjects: 54
Study 15773839 — intervention group
Group type: EXPERIMENTAL
Intervention: Posterior partial fundoplication
Number of subjects: 24
Study 15773839 — intervention group
Group type: COMPARATOR
Intervention: Anterior partial fundoplication
Number of subjects: 24
Study 12635468 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin 10 mg daily for 6 weeks, increased to 20 mg daily if LDL cholesterol goal not achieved
Number of subjects: 14
Study 12635468 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin 10 mg daily for 6 weeks, increased to 20 mg daily if LDL cholesterol goal not achieved
Number of subjects: 14
Study 10337458 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical dimethindene maleate (DMM) gel
Number of subjects: 24
Study 10337458 — intervention group
Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 24
Study 8975289 — intervention group
Group type: EXPERIMENTAL
Intervention: Reactive gastritis (RG) in diabetics
Number of subjects: 152
Study 8975289 — intervention group
Group type: EXPERIMENTAL
Intervention: Reactive gastritis (RG) in diabetics after excluding NSAIDs use or cholecystectomy
Number of subjects: 152
Study 8975289 — intervention group
Group type: EXPERIMENTAL
Intervention: Helicobacter pylori (Hp) infection in diabetics with RG
Number of subjects: 152
Study 8975289 — intervention group
Group type: EXPERIMENTAL
Intervention: Autonomic neuropathy (AN) in diabetics with RG
Number of subjects: 152
Study 8975289 — intervention group
Group type: COMPARATOR
Intervention: Helicobacter pylori (Hp) infection in diabetics with CAG
Number of subjects: 152
Study 8975289 — intervention group
Group type: COMPARATOR
Intervention: Autonomic neuropathy (AN) in diabetics with CAG
Number of subjects: 152
Study 2010305 — intervention group
Group type: EXPERIMENTAL
Intervention: Radioimmunoscintigraphy (RIS)
Number of subjects: 59
Study 2010305 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI
Number of subjects: 59
Study 2010305 — intervention group
Group type: EXPERIMENTAL
Intervention: CT scan
Number of subjects: 59
Study 2010305 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound (US)
Number of subjects: 59
Study 7091037 — intervention group
Group type: EXPERIMENTAL
Intervention: Piperazine
Number of subjects: 159
Study 7091037 — intervention group
Group type: EXPERIMENTAL
Intervention: Metronidazole
Number of subjects: 159
Study 7091037 — intervention group
Group type: EXPERIMENTAL
Intervention: Piperazine and Metronidazole
Number of subjects: 159
Study 7091037 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 159
Study 30938895 — intervention group
Group type: EXPERIMENTAL
Intervention: IRA-LTC scale (self-developed structured questionnaire consisting of 31 items)
Number of subjects: 458
Study 30938895 — intervention group
Group type: EXPERIMENTAL
Intervention: IRA-LTC scale
Number of subjects: 458
Study 29784004 — intervention group
Group type: EXPERIMENTAL
Intervention: Retrograde autologous priming (RAP)
Number of subjects: 118
Study 29784004 — intervention group
Group type: COMPARATOR
Intervention: Non-RAP (control group)
Number of subjects: 118
Study 27381786 — intervention group
Group type: EXPERIMENTAL
Intervention: Lottery scratch cards included with the form
Number of subjects: 6795
Study 27381786 — intervention group
Group type: EXPERIMENTAL
Intervention: Prize draw for a tablet computer
Number of subjects: 6795
Study 27381786 — intervention group
Group type: EXPERIMENTAL
Intervention: No financial incentive
Number of subjects: 6795
Study 27381786 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone reminder calls
Number of subjects: 6795
Study 27381786 — intervention group
Group type: COMPARATOR
Intervention: Control group (not offered colonoscopy)
Number of subjects: 6795
Study 27381786 — intervention group
Group type: COMPARATOR
Intervention: Lottery scratch cards in control group
Number of subjects: 6795
Study 27381786 — intervention group
Group type: COMPARATOR
Intervention: Prize draw in control group
Number of subjects: 6795
Study 23754631 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 g Spirulina (Arthrospira platensis) per day for 12 weeks
Number of subjects: 52
Study 23405800 — intervention group
Group type: EXPERIMENTAL
Intervention: Erdi Biejia Decoction
Number of subjects: 60
Study 23405800 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 19786668 — intervention group
Group type: EXPERIMENTAL
Intervention: GC (gemcitabine 1,000 mg/m(2) on days 1 and 8 and carboplatin AUC 4.5 for 21 days)
Number of subjects: 178
Study 19786668 — intervention group
Group type: COMPARATOR
Intervention: M-CAVI (methotrexate 30 mg/m(2) on days 1, 15, and 22; carboplatin AUC 4.5 on day 1; and vinblastine 3 mg/m(2) on days 1, 15, and 22 for 28 days)
Number of subjects: 178
Study 19786668 — intervention group
Group type: EXPERIMENTAL
Intervention: GC
Number of subjects: 178
Study 19786668 — intervention group
Group type: COMPARATOR
Intervention: M-CAVI
Number of subjects: 178
Study 18329225 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized psychosocial protocol (Matrix model)
Number of subjects: 784
Study 18329225 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual
Number of subjects: 784
Study 16202854 — intervention group
Group type: EXPERIMENTAL
Intervention: Felodipine + Metoprolol (F+M) 5 + 50 mg
Number of subjects: 947
Study 16202854 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril (E) 10 mg
Number of subjects: 947
Study 16202854 — intervention group
Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 947
Study 12374438 — intervention group
Group type: EXPERIMENTAL
Intervention: Talking while solving reasoning problems (Study 1)
Number of subjects: 0
Study 12374438 — intervention group
Group type: EXPERIMENTAL
Intervention: Beliefs about talking and thinking (Study 2)
Number of subjects: 0
Study 12374438 — intervention group
Group type: EXPERIMENTAL
Intervention: Talking while solving reasoning problems (Study 3)
Number of subjects: 0
Study 10021304 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemoradiotherapy (whole abdominal radiation 30 Gy over 4 weeks, additional 21.6 Gy to pelvis, 12 Gy to paraaortic region)
Number of subjects: 64
Study 10021304 — intervention group
Group type: COMPARATOR
Intervention: Adjuvant chemotherapy only
Number of subjects: 64
Study 10021304 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemoradiotherapy (specifically for stage III patients)
Number of subjects: 64
Study 10021304 — intervention group
Group type: COMPARATOR
Intervention: Adjuvant chemotherapy only (specifically for stage III patients)
Number of subjects: 64
Study 7498988 — intervention group
Group type: EXPERIMENTAL
Intervention: Atrial natriuretic factor (1.6 pmol/kg per minute) plus saline
Number of subjects: 11
Study 7498988 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral candoxatril (200 mg) plus saline
Number of subjects: 11
Study 7498988 — intervention group
Group type: COMPARATOR
Intervention: Intravenous saline
Number of subjects: 11
Study 2110033 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate invasive strategy
Number of subjects: 586
Study 2110033 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed invasive strategy
Number of subjects: 586
Study 2110033 — intervention group
Group type: EXPERIMENTAL
Intervention: Conservative strategy
Number of subjects: 586
Study 2110033 — intervention group
Group type: COMPARATOR
Intervention: All groups
Number of subjects: 586
Study 111332 — intervention group
Group type: EXPERIMENTAL
Intervention: Group I: 40 Kcal/kg/day and 250 mg nitrogen/day
Number of subjects: 30
Study 111332 — intervention group
Group type: EXPERIMENTAL
Intervention: Group II: 30 Kcal/kg/day and 175 mg nitrogen/kg/24 hours
Number of subjects: 30
Study 111332 — intervention group
Group type: EXPERIMENTAL
Intervention: Group III: 20 Kcal/kg/day and 100 mg nitrogen/kg/24 hours
Number of subjects: 30
Study 30897933 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug-coated balloon (DCB)
Number of subjects: 26
Study 30897933 — intervention group
Group type: COMPARATOR
Intervention: Percutaneous transluminal angioplasty (PTA)
Number of subjects: 26
Study 29560074 — intervention group
Group type: EXPERIMENTAL
Intervention: Static technique
Number of subjects: 120
Study 29560074 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic technique
Number of subjects: 120
Study 27052541 — intervention group
Group type: EXPERIMENTAL
Intervention: Food4Me food-frequency questionnaire (FFQ)
Number of subjects: 567
Study 23660574 — intervention group
Group type: EXPERIMENTAL
Intervention: Wii boxing
Number of subjects: 22
Study 23660574 — intervention group
Group type: EXPERIMENTAL
Intervention: Wii tennis
Number of subjects: 22
Study 23660574 — intervention group
Group type: COMPARATOR
Intervention: Wii games (any)
Number of subjects: 22
Study 23660574 — intervention group
Group type: EXPERIMENTAL
Intervention: Boxing and cycling
Number of subjects: 22
Study 23660574 — intervention group
Group type: EXPERIMENTAL
Intervention: Boxing and tennis
Number of subjects: 22
Study 22641306 — intervention group
Group type: EXPERIMENTAL
Intervention: Capnographic monitoring
Number of subjects: 760
Study 22641306 — intervention group
Group type: COMPARATOR
Intervention: Standard monitoring
Number of subjects: 760
Study 20556840 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual specimens (antrum + body)
Number of subjects: 355
Study 20556840 — intervention group
Group type: COMPARATOR
Intervention: Single antral specimens
Number of subjects: 355
Study 20556840 — intervention group
Group type: EXPERIMENTAL
Intervention: Newly developed rapid urease tests (HelicotecUT plus test and HelicotecUT test)
Number of subjects: 355
Study 20556840 — intervention group
Group type: COMPARATOR
Intervention: Established rapid urease tests (CLO test and ProntoDry test)
Number of subjects: 355
Study 17432689 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine therapy plus Chinese medicinal compound for EWEPPB
Number of subjects: 68
Study 17432689 — intervention group
Group type: COMPARATOR
Intervention: Routine Western therapy alone
Number of subjects: 68
Study 15803833 — intervention group
Group type: COMPARATOR
Intervention: Cytostatic therapy
Number of subjects: 105
Study 15803833 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytostatic and antibacterial agents
Number of subjects: 105
Study 15803833 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytostatic and antibacterial agents with prebiotic preparations
Number of subjects: 105
Study 11834137 — intervention group
Group type: EXPERIMENTAL
Intervention: Brachial artery mean 24 h pulse pressure
Number of subjects: 60
Study 11834137 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined multivariate model
Number of subjects: 60
Study 11834137 — intervention group
Group type: EXPERIMENTAL
Intervention: Brachial artery pulse pressure
Number of subjects: 60
Study 10632027 — intervention group
Group type: EXPERIMENTAL
Intervention: Histamine injection in area of allodynia (experimental arm)
Number of subjects: 0
Study 10632027 — intervention group
Group type: COMPARATOR
Intervention: Histamine injection in opposite forearm (control arm)
Number of subjects: 0
Study 10632027 — intervention group
Group type: COMPARATOR
Intervention: Comparison of wheal and flare areas between experimental and control arms
Number of subjects: 0
Study 7717489 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine management with additional forced-air warming of head, chest, and arms
Number of subjects: 20
Study 7717489 — intervention group
Group type: COMPARATOR
Intervention: Routine thermal management (circulating-water mattress set at 42 degrees C, intravenous fluid warming to 37 degrees C and passive insulation)
Number of subjects: 20
Study 2149553 — intervention group
Group type: EXPERIMENTAL
Intervention: CBM goal and progress monitoring with group follow‐up consultation
Number of subjects: 55
Study 2149553 — intervention group
Group type: EXPERIMENTAL
Intervention: CBM goal and progress monitoring with individual expert follow‐up consultation
Number of subjects: 55
Study 2149553 — intervention group
Group type: EXPERIMENTAL
Intervention: teacher‐developed goal and progress monitoring with group follow‐up consultation
Number of subjects: 55
Study 2149553 — intervention group
Group type: EXPERIMENTAL
Intervention: teacher‐developed goal and progress monitoring with individual expert follow‐up consultation
Number of subjects: 55
Study 7172410 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednimustine + vincristine
Number of subjects: 67
Study 7172410 — intervention group
Group type: COMPARATOR
Intervention: Cytosine arabinoside + thioguanine
Number of subjects: 67
Study 31777119 — intervention group
Group type: EXPERIMENTAL
Intervention: Colour star rating only
Number of subjects: 1033
Study 31777119 — intervention group
Group type: EXPERIMENTAL
Intervention: Coloured HSR variations
Number of subjects: 1033
Study 31777119 — intervention group
Group type: EXPERIMENTAL
Intervention: Star-only versions
Number of subjects: 1033
Study 31777119 — intervention group
Group type: COMPARATOR
Intervention: B&W full HSR
Number of subjects: 1033
Study 31252032 — intervention group
Group type: EXPERIMENTAL
Intervention: Dupilumab (200 mg weekly)
Number of subjects: 54
Study 31252032 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study 29482038 — intervention group
Group type: EXPERIMENTAL
Intervention: Treat-to-target intervention
Number of subjects: 212
Study 29482038 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 212
Study 27470989 — intervention group
Group type: EXPERIMENTAL
Intervention: 30-day ECG monitoring
Number of subjects: 0
Study 27470989 — intervention group
Group type: EXPERIMENTAL
Intervention: 7-day ECG monitoring
Number of subjects: 0
Study 27470989 — intervention group
Group type: EXPERIMENTAL
Intervention: 14-day ECG monitoring
Number of subjects: 0
Study 27470989 — intervention group
Group type: COMPARATOR
Intervention: Repeat 24-hour ECG
Number of subjects: 0
Study 24239808 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet-congruent images
Number of subjects: 67
Study 24239808 — intervention group
Group type: COMPARATOR
Intervention: Control images (neutral non-food images)
Number of subjects: 67
Study 22101225 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged Exposure (PE) therapy delivered via home-based telehealth (HBT)
Number of subjects: 0
Study 22101225 — intervention group
Group type: COMPARATOR
Intervention: Prolonged Exposure (PE) therapy delivered in-person
Number of subjects: 0
Study 20802288 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined weight and pendulum training exercises
Number of subjects: 38
Study 20802288 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight training
Number of subjects: 38
Study 16823457 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcon AcrySof IOL (MA60AC)
Number of subjects: 45
Study 16823457 — intervention group
Group type: COMPARATOR
Intervention: AMO Sensar IOL (AR40e)
Number of subjects: 45
Study 16823457 — intervention group
Group type: EXPERIMENTAL
Intervention: Both IOL groups
Number of subjects: 45
Study 16893989 — intervention group
Group type: EXPERIMENTAL
Intervention: TT homozygotes
Number of subjects: 300
Study 15641542 — intervention group
Group type: EXPERIMENTAL
Intervention: Pleural tent
Number of subjects: 40
Study 15641542 — intervention group
Group type: COMPARATOR
Intervention: Control group without pleural tent
Number of subjects: 40
Study 10821361 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan (titrated to 50 mg once daily)
Number of subjects: 3152
Study 10821361 — intervention group
Group type: COMPARATOR
Intervention: Captopril (titrated to 50 mg three times daily)
Number of subjects: 3152
Study 8773906 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute exacerbations in chronic hepatitis C
Number of subjects: 194
Study 8773906 — intervention group
Group type: EXPERIMENTAL
Intervention: Asymptomatic acute exacerbations
Number of subjects: 194
Study 8773906 — intervention group
Group type: EXPERIMENTAL
Intervention: Histological study of acute exacerbations
Number of subjects: 194
Study 8773906 — intervention group
Group type: EXPERIMENTAL
Intervention: Alanine aminotransferase > or = 300 U/l at entry
Number of subjects: 194
Study 8773906 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic active hepatitis at entry
Number of subjects: 194
Study 8773906 — intervention group
Group type: EXPERIMENTAL
Intervention: HCV‐RNA level during acute exacerbations
Number of subjects: 194
Study 1467375 — intervention group
Group type: EXPERIMENTAL
Intervention: CCK‐4 (10 micrograms)
Number of subjects: 29
Study 1467375 — intervention group
Group type: EXPERIMENTAL
Intervention: CCK‐4 (15 micrograms)
Number of subjects: 29
Study 1467375 — intervention group
Group type: EXPERIMENTAL
Intervention: CCK‐4 (20 micrograms)
Number of subjects: 29
Study 1467375 — intervention group
Group type: EXPERIMENTAL
Intervention: CCK‐4 (25 micrograms)
Number of subjects: 29
Study 1467375 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study 6699655 — intervention group
Group type: EXPERIMENTAL
Intervention: Irradiation
Number of subjects: 0
Study 6699655 — intervention group
Group type: COMPARATOR
Intervention: Mastectomy
Number of subjects: 0
Study 30808080 — intervention group
Group type: EXPERIMENTAL
Intervention: udenafil 50 mg (U50)
Number of subjects: 18
Study 30808080 — intervention group
Group type: EXPERIMENTAL
Intervention: udenafil 100 mg (U100)
Number of subjects: 18
Study 30808080 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 18
Study 29321654 — intervention group
Group type: EXPERIMENTAL
Intervention: Information and behavioral nudges (including soft commitments and reminders)
Number of subjects: 0
Study 29321654 — intervention group
Group type: EXPERIMENTAL
Intervention: Approaching expecting parents closer to the delivery date and providing multiple reminders
Number of subjects: 0
Study 29321654 — intervention group
Group type: EXPERIMENTAL
Intervention: Organizational support
Number of subjects: 0
Study 26713336 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced ICF
Number of subjects: 550
Study 26713336 — intervention group
Group type: COMPARATOR
Intervention: Conventional ICF
Number of subjects: 550
Study 24815831 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine abdominal computed tomography (rCT)
Number of subjects: 203
Study 24815831 — intervention group
Group type: COMPARATOR
Intervention: Selective abdominal CT (sCT)
Number of subjects: 203
Study 22926591 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvoxamine (titrated up to 150 mg/d)
Number of subjects: 48
Study 22926591 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 20601209 — intervention group
Group type: EXPERIMENTAL
Intervention: Acu-TENS
Number of subjects: 28
Study 20601209 — intervention group
Group type: COMPARATOR
Intervention: Placebo-TENS
Number of subjects: 28
Study 20601209 — intervention group
Group type: COMPARATOR
Intervention: Sham-TENS
Number of subjects: 28
Study 17660033 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapamycin therapy
Number of subjects: 46
Study 17660033 — intervention group
Group type: COMPARATOR
Intervention: Tacrolimus plus rapamycin
Number of subjects: 46
Study 17660033 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term rapamycin treatment
Number of subjects: 46
Study 16098002 — intervention group
Group type: EXPERIMENTAL
Intervention: Esomeprazole 20 mg/day
Number of subjects: 6017
Study 16098002 — intervention group
Group type: COMPARATOR
Intervention: Esomeprazole on demand
Number of subjects: 6017
Study 16098002 — intervention group
Group type: EXPERIMENTAL
Intervention: Esomeprazole 40 mg/day (acute treatment)
Number of subjects: 6017
Study 12137725 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentoxifylline 1200 mg per day (3 x 400 mg) orally in addition to local therapy
Number of subjects: 80
Study 12137725 — intervention group
Group type: COMPARATOR
Intervention: Local therapy alone
Number of subjects: 80
Study 12137725 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentoxifylline 1200 mg per day
Number of subjects: 80
Study 10455830 — intervention group
Group type: EXPERIMENTAL
Intervention: Light diet (eating group)
Number of subjects: 94
Study 7805224 — intervention group
Group type: EXPERIMENTAL
Intervention: 60-microF capacitance biphasic pulse
Number of subjects: 38
Study 7805224 — intervention group
Group type: EXPERIMENTAL
Intervention: 120-microF capacitance biphasic pulse
Number of subjects: 38
Study 1704545 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonlinear algorithm
Number of subjects: 11
Study 1704545 — intervention group
Group type: COMPARATOR
Intervention: Linear algorithm
Number of subjects: 11
Study 5895 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic fetal monitoring
Number of subjects: 483
Study 5895 — intervention group
Group type: COMPARATOR
Intervention: Auscultation of fetal heart tones
Number of subjects: 483
Study 30622047 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavior therapy (CBT)
Number of subjects: 64
Study 30622047 — intervention group
Group type: EXPERIMENTAL
Intervention: Acceptance and commitment therapy (ACT)
Number of subjects: 64
Study 30622047 — intervention group
Group type: COMPARATOR
Intervention: Waitlist (Control)
Number of subjects: 64
Study 28500682 — intervention group
Group type: EXPERIMENTAL
Intervention: Transfusion
Number of subjects: 204
Study 28500682 — intervention group
Group type: COMPARATOR
Intervention: Hydroxyurea use
Number of subjects: 204
Study 25506771 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (proactive outreach with counseling, NRT, community referrals)
Number of subjects: 707
Study 25506771 — intervention group
Group type: COMPARATOR
Intervention: Usual care group
Number of subjects: 707
Study 25506771 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone counseling participation
Number of subjects: 707
Study 25506771 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of community referral
Number of subjects: 707
Study 23511989 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-arterial chemotherapy combined with intravesical chemotherapy (group A)
Number of subjects: 60
Study 23511989 — intervention group
Group type: COMPARATOR
Intervention: Intravesical chemotherapy alone (group B)
Number of subjects: 60
Study 16454146 — intervention group
Group type: EXPERIMENTAL
Intervention: Hatha yoga class
Number of subjects: 135
Study 16454146 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking exercise class
Number of subjects: 135
Study 16454146 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 135